From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach

Zowalaty, Mohamed E. El; Järhult, Josef D.

doi:10.1016/j.onehlt.2020.100124

Cited by 349 publications

(312 citation statements)

References 44 publications

Supporting

Mentioning

288

Contrasting

Unclassified

Order By: Relevance

“…To address such challenges, where a rapidly changing environment and animal health may impact human health, the framework of a 'One Health' approach comes into consideration [307]. The One Health approach is basically an integration of transdisciplinary sectors addressing animal, human, and ecosystem health for the well-being of the entire ecosystem [308,309]. The One Health approach may facilitate effective intervention in emerging infectious virus diseases through a multidisciplinary dimension from animal, human, and ecosystem perspectives, which simply would not be possible by adopting just a one-dimensional approach.…”

Section: Discussionmentioning

confidence: 99%

“…The One Health approach may facilitate effective intervention in emerging infectious virus diseases through a multidisciplinary dimension from animal, human, and ecosystem perspectives, which simply would not be possible by adopting just a one-dimensional approach. The primary objective of the One Health approach is to mitigate the risk of disease outbreaks across all three constituent domains, including animals, humans, and the environment [307,309].…”

Section: Discussionmentioning

confidence: 99%

“…The recent emergence of zoonotic-origin SARS-CoV-2 [309,310] in December 2019 in Wuhan, China and its spread to more than 200 countries all over the world, as of the date of this publication, causing more than two million human infections worldwide and more than 130,000 deaths worldwide [311], is of great global public health concern. The WHO declared COVID-19 a pandemic on 11 March 2020 [312].…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

et al. 2020

Self Cite

View full text Add to dashboard Cite

Emerging and re-emerging viral diseases are of great public health concern. The recent emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV-2) in December 2019 in China, which causes COVID-19 disease in humans, and its current spread to several countries, leading to the first pandemic in history to be caused by a coronavirus, highlights the significance of zoonotic viral diseases. Rift Valley fever, rabies, West Nile, chikungunya, dengue, yellow fever, Crimean-Congo hemorrhagic fever, Ebola, and influenza viruses among many other viruses have been reported from different African countries. The paucity of information, lack of knowledge, limited resources, and climate change, coupled with cultural traditions make the African continent a hotspot for vector-borne and zoonotic viral diseases, which may spread globally. Currently, there is no information available on the status of virus diseases in Africa. This systematic review highlights the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa. The findings will help us understand the trend of emerging and re-emerging virus diseases within the African continent. The findings recommend active surveillance of viral diseases and strict implementation of One Health measures in Africa to improve human public health and reduce the possibility of potential pandemics due to zoonotic viruses.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the~7 years between April 2012 and November 2019, there were 2494 laboratory-confirmed cases of infection with Middle East respiratory syndrome coronavirus (MERS-CoV) that reached 27 countries and had a mortality rate of approximately 34% [4], though serologic studies have implied that the prevalence of MERS-CoV may have been underestimated [5]. Most recently, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 in Wuhan and its subsequent spread to over 160 countries across the world has generated intense interest in vaccine development and treatment options for coronavirus disease 2019 (COVID-19) [6,7].…”

Section: Introductionmentioning

confidence: 99%

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses

2020

View full text Add to dashboard Cite

Recent international epidemics of coronavirus-associated illnesses underscore the urgent medical and public health need for vaccine development and regulatory body approved therapies. In particular, the current coronavirus disease 2019 (COVID-19) pandemic has quickly intensified interest in developing treatment options to mitigate impact on human life. Remdesivir (GS-5734™) is a broad-spectrum antiviral drug that is now being tested as a potential treatment for COVID-19 in international, multi-site clinical trials. Currently available evidence about the antiviral effects of remdesivir against coronaviruses is primarily based on in vitro and in vivo studies (including some on a chemically related compound, GS-441524™), which have demonstrated largely favorable findings. As the pandemic progresses, information from human compassionate use cases will continue to accumulate before the clinical trials are concluded. It is imperative for public health practitioners and the One Health community to stay up to date on the most promising potential therapeutic options that are under investigation. Thus, the purpose of this review is to synthesize the knowledge to date about remdesivir as a therapeutic option for coronaviruses, with a special focus on information relevant to the One Health community.

show abstract

“…We here want to draw attention to another important and noteworthy feature of the Anthropocene which greatly affects public health, human well-being, and economic performance. These findings are especially pertinent as the world reels from the health, social and economic impact of the current SARS-CoV-2 pandemic (El Zowalaty and Järhult, 2020;Ghebreyesus and Swaminathan, 2020;Lorusso et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

The accelerated infectious disease risk in the Anthropocene: more outbreaks and wider global spread

Morand

Walther

2020

Preprint

View full text Add to dashboard Cite

The greatly accelerated economic growth during the Anthropocene has resulted in astonishing improvements in many aspects of human well-being, but has also caused the acceleration of risks, such as the interlinked biodiversity and climate crisis. Here, we report on another risk: the accelerated infectious disease risk associated with the number and geographic spread of human infectious disease outbreaks. Using the most complete, reliable, and up-to-date database on human infectious disease outbreaks (GIDEON), we show that the number of disease outbreaks, the number of diseases involved in these outbreaks, and the number of countries affected have increased during the entire Anthropocene. Furthermore, the spatial distribution of these outbreaks is becoming more globalized in the sense that the overall modularity of the disease networks across the globe has decreased, meaning disease outbreaks have become increasingly pandemic in their nature. This decrease in modularity is correlated with the increase in air traffic. We finally show that those countries and regions which are most central within these disease networks tend to be countries with higher GDPs. Therefore, one cost of increased global mobility and greater economic growth is the increased risk of disease outbreaks and their faster and wider spread. We briefly discuss three different scenarios which decision-makers might follow in light of our results.

show abstract

From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans – Call for a One Health approach

Cited by 349 publications

References 44 publications

Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses

The accelerated infectious disease risk in the Anthropocene: more outbreaks and wider global spread

Contact Info

Product

Resources

About